A Guidance Document for Implementing Effective Cancer Clinical Trials

Posted: Apr 22, 2010
C-Change and the Coalition of Cancer Cooperative Groups. 2005 Jun 07.
KEYWORDS: Institutional Issues, Regulatory Issues, Consent, Cancer


This document provides policymakers, cancer researchers, institutions, and trial funding sources with information regarding regulatory requirements and guidance on the functional requirements and costs associated with conducting Phase II and III cancer clinical trials.


This document identifies operational and cost benchmarks for sites currently conducting cancer clinical trials, offers sites interested in or recently new to clinical trials guidance from experienced clinical trial organizations, and examines how the costs associated with conducting clinical trials compare to reimbursement levels for trial participation.